KOKenichiro Otsuka

Kenichiro Otsuka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kenichiro Otsuka has a total of 156 co-authors. Here are the top co-authors by number of shared publications:

  • Daiju Fukuda

    16 shared publications
  • Noriaki Kasayuki

    Department of Cardiovascular Medicine, Kashibaseiki Hospital , Kashiba, Nara 639-0252

    14 shared publications
  • Kenei Shimada

    Department of Cardiovascular Medicine, Kashibaseiki Hospital , Kashiba, Nara 639-0252

    12 shared publications
  • Yasushi Kono

    Department of Cardiovascular Medicine, Fujiikai Kashibaseiki Hospital

    8 shared publications
  • Hiroki Yamaura

    Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahicho, Abenoku, Osaka, 545-8585, Japan

    7 shared publications
  • Hirotoshi Ishikawa

    Department of Cardiovascular Medicine, Fujiikai Kashibaseiki Hospital

    7 shared publications

Latest Publications

  • Open Access

    Prehospital prognostication after out-of-hospital cardiac arrest in tertiary care centers: the R-EDByUS score in the JAAM-OHCA registry

    by Takenobu Shimada, Ryota Kawai, Ayumi Shintani, Satoshi Kodera, Naoki Fujisawa, Wataru Saitoh, Yoshihiro Iwasaki, Takefumi Kishimori, Sakae Matsuzuka, Yusuke Hayashi, et al.


  • Open Access

    Does ECG-Based AI Detect Aortic Stenosis Beyond Conventional LVH Criteria? An Analysis of the CLIDAS Database

    by Takenobu Shimada, Satoshi Kodera, Shinnosuke Sawano, JingChuan Guan, Wataru Saitoh, Shiho Wakasa, Shinji Ito, Tomoya Yanagishita, Yusuke Hayashi, Atsushi Shibata, et al.

    Background: Aortic stenosis (AS) is a progressive valvular disease associated with poor prognosis once symptoms develop, yet routine echocardiographic screening is impractical. While artificial intelligence (AI)-based electrocardiogram (ECG) models have shown promise for AS detection, it remains unclear whether they primarily reflect conventional left ventricular hypertrophy (LVH) voltage criteria or capture additional ECG features. Methods and Results: We developed a deep learning model using 244,816 ECGs from 51,713 patients across six academic institutions in Japan (CLIDAS database). AS labels were derived from inpatient Diagnosis Procedure Combination (DPC) codes. The model achieved an area under the receiver operating characteristic curve (AUC) of 0.849 (95% confidence interval 0.832–0.865) in the independent test cohort, with consistent performance across institutions, sex, and age. At a threshold of 0.1, sensitivity was 79.1%, specificity was 73.9%, and negative predictive value (NPV) was 98.0%. Conventional LVH voltage criteria (Sokolow–Lyon AUC 0.706; Cornell AUC 0.692) showed lower performance, and adding them to the AI model conferred no incremental benefit (AUC 0.849 vs. 0.847). Gradient-weighted class activation mapping (Grad-CAM) revealed predominant attention around QRS complexes in limb leads, beyond regions typically assessed in LVH evaluation. Conclusions: This multicenter AI-ECG model demonstrated strong discrimination for AS and captured ECG features beyond conventional LVH voltage criteria. The high NPV supports its use as a rule-out pre-screening tool.

  • Open Access

    Acquired Hemophilia A During Prasugrel Therapy After Recurrent Acute Coronary Syndrome

    by Shumpei Yao, Naoki Fujisawa, Kenichiro Otsuka, Joji Nagasaki, Takumi Kawase, Yosuke Takahashi, Daiju Fukuda


  • Open Access

    Symptom phenotypes and coronary microvascular function in non-obstructive coronary artery disease: Insights beyond epicardial ischemia

    by Kotaro Matsumoto, Kenichiro Otsuka, Shunsuke Kagawa, Hiroki Yamaura, Tsubasa Miura, Kazuya Sugioka, Wataru Saitoh, Akihiro Okamoto, Go Kajio, Naoki Fujisawa, et al.


  • Open Access

    Integration of BNP and blood glucose for identifying coronary flow reserve impairment: A cardiovascular–kidney–metabolic perspective

    by Kotaro Matsumoto, Kenichiro Otsuka, Shunsuke Kagawa, Hiroki Yamaura, Tsubasa Miura, Kazuya Sugioka, Wataru Saitoh, Akihiro Okamoto, Go Kajio, Naoki Fujisawa, et al.


  • Open Access

    High levels of pericoronary adipose tissue inflammation are associated with coronary atherosclerosis independent of epicardial adipose tissue volume in patients with chronic coronary syndrome

    by Hiroki Yamaura, Kenichiro Otsuka, Hirotoshi Ishikawa, Kana Hojo, Kotaro Matsumoto, Naoki Fujisawa, Akihiro Okamoto, Tomohiro Yamaguchi, Shunsuke Kagawa, Takenobu Shimada, et al.

    Aims: This study aimed to assess clinical risks and coronary atherosclerotic burden in patients with chronic coronary syndrome (CCS) stratified by pericoronary artery adipose tissue (PCAT) composition and epicardial adipose tissue volume (EAV). Methods and results: We retrospectively included 410 CCS patients who underwent coronary computed tomography angiography. Patients were divided into four groups based on an EAV index ≥ 73.5 mL/mm2 and PCAT attenuation (PCATA) in the right coronary artery (PCATARCA) ≥ −76.6 HU (above median); Groups A (low EAV index and low PCATARCA), B (low EAV index and high PCATARCA), C (high EAV index and low PCATARCA), and D (high EAV index and high PCATARCA). Multivariable models assessed the relative risk of coronary artery calcium score (CACS) > 400 and coronary artery disease (CAD), and predictors of coronary plaque volume. The log-transformed CACS increased progressively, with Group D showing the highest values. Group D had the highest prevalence of Hisayama risk score of 10-year risk > 10%, CACS > 400, and CAD. The high EAVi group (C and D) showed increased risks of CACS > 400 [Group C: adjusted odds ratio, 6.30; 95% confidence interval (CI), 1.39–28.6; Group D: adjusted odds ratio, 9.13; 95% CI, 2.00–41.5] and CAD (Group C: adjusted odds ratio, 2.33; 95% CI, 1.13–4.83; Group D: adjusted odds ratio, 9.13; 95% CI, 2.00–41.5). Multivariate linear regression analysis demonstrated that PCATARCA was associated with a greater plaque volume independent of EAV index. Conclusion: Elevated PCAT inflammation is associated with the coronary plaque burden independent of EAV index in patients with CCS. Lay summary: • This study demonstrates that distinct phenotypes based on ectopic fat volume and composition—the volume of epicardial adipose tissue (EAT) and the inflammation status of pericoronary adipose tissue (PCAT)—can characterize coronary atherosclerotic disease burden in patients with chronic coronary syndrome. • While both increased EAT volume and PCAT inflammation have been reportedly associated with coronary artery disease (CAD) and cardiovascular events, evidence investigating the association of EAT volume and PCAT inflammation with CAD disease burden is limited. • Patients with increased EAT volume are at an elevated risk for coronary artery calcification and increased plaque burden, regardless of PCAT inflammation. In contrast, among patients without increased EAT volume, increased PCAT inflammation is correlated with an increased risk of coronary artery calcification and plaque burden.


  • Open Access

    Utility of the CHADS-P2A2RC score for estimating net adverse clinical events in chronic coronary syndrome patients without atrial fibrillation: insights from the CLIDAS-PCI

    by Takenobu Shimada, Daiju Fukuda, Atsushi Shibata, Kenichiro Otsuka, Asahiro Ito, Hiroshi Okamura, Tetsuya Matoba, Takahide Kohro, Yusuke Oba, Tomoyuki Kabutoya, et al.

    Background: There are few data verifying the utility of the CHADS-P2A2RC score in comparison with the CHADS2 score for estimating net adverse clinical events (NACE) in real-world settings. Methods: We performed analysis for a total of 3,985 chronic coronary syndrome (CCS) patients without atrial fibrillation (AF) who underwent percutaneous coronary intervention (PCI) between April 2013 and March 2019 for whom information was obtained from the CLIDAS (Clinical Deep Data Accumulation System)-PCI database. The primary endpoint was NACE defined as the composite of 3-point major adverse cardiovascular events (3P-MACE) (cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke) and GUSTO moderate/severe bleeding events. Results: Kaplan-Meier analysis showed that both the CHADS-P2A2RC and CHADS2 scores stratified the risks. The incidences of NACE were stratified well by the very-high-risk category, which was uniquely defined as a CHADS-P2A2RC score of ≥6 (hazard ratio: 2.38, 95% CI=1.91-2.97, p-value <0.001). The area under the curve (AUC) in estimating NACE within 3 years was higher when the CHADS-P2A2RC score was used than when the CHADS2 score was used (0.67 vs. 0.62, p=0.003). This was mainly due to the accuracy in estimating bleeding events (0.66 vs. 0.60, p=0.006). Conclusions: The accuracy in estimating NACE after PCI for CCS patients without AF was higher when the CHADS-P2A2RC score was used than when the CHADS2 score was used, mainly due to the accuracy in predicting bleeding risk. Higher incidences of endpoints were well-stratified by a very-high-risk category defined as a CHADS-P2A2RC score of ≥6.

  • Open Access

    First-in-human intravascular polarimetric signatures of superficial femoral artery in-stent restenosis lesion

    by Takenobu Shimada, Kenichiro Otsuka, Naoki Fujisawa, Takanori Yamazaki

    Takenobu Shimada, MD, Kenichiro Otsuka, MD, PhD, Naoki Fujisawa, MD, Takanori Yamazaki, MD, PhD, Grigoris Karamasis; First-in-human intravascular polarimet

  • Intracoronary polarimetric signatures of exercise-induced vasospastic angina

    by Takenobu Shimada, Naoki Fujisawa, Kenichiro Otsuka

    A 46-year-old male was admitted to our hospital due to ST-segment elevation myocardial infarction (STEMI). He had felt chest pain several times during exercise before admission. Emergent invasive coronary angiography (ICA) revealed total occlusion at the proximal part of the left anterior descending coronary artery, and optical coherence tomography (OCT) confirmed rupture of atherosclerotic plaques, where a drug-eluting stent was successfully implanted. On the seventh day, during an exercise test to assess cardiopulmonary function, he had severe chest pain with ST-segment elevation in II, III, and aVF leads. Since STEMI recurrence was suspected, emergent ICA was performed immediately. Invasive coronary angiography revealed severe stenosis at the proximal part of the right coronary artery (Panel A). We evaluated the lesion with polarization-sensitive OCT, which measures birefringence that is elevated in collagen and collagen-synthesizing smooth muscle cells.1 Polarization-sensitive OCT showed intimal folding that resulted in multiple kinks of the luminal contour, so-called intimal gathering,2 with high birefringent tissues in laminae (Panels B and C; Supplementary data online, Video S1). After injection of nitrate, the stenosis disappeared angiographically (Panel D), and polarization-sensitive OCT revealed the resolution of intimal gathering with the high birefringence area becoming sparse within the thickened intimal layer, while the external elastic lamina area was enlarged (Panels E and F). These findings suggest that vasospasm was caused by temporal contraction of the medial layer together with intimal gathering. The thickened intima remaining after resolution of vasospasm suggested that vasospasm had occurred repeatedly before these events. Following administration of calcium channel blockers, his chest symptom disappeared even during exercise.

  • Open Access

    Thoracic Aortic Plaque Burden and Prediction of Cardiovascular Events in Patients Undergoing 320-row Multidetector CT Coronary Angiography

    by Kenichiro Otsuka, Hirotoshi Ishikawa, Hiroki Yamaura, Kana Hojo, Yasushi Kono, Kenei Shimada, Noriaki Kasayuki, Daiju Fukuda

    Aim: Wide volume scan (WVS) coronary computed tomography angiography (CCTA) enables aortic arch visualization. This study assessed whether the thoracic aortic plaque burden (TAPB) score can predict major cardiovascular adverse events (MACE) in addition to and independently of other obstructive coronary artery disease (CAD) attributes. Methods: This study included patients with suspected CAD who underwent CCTA (n=455). CCTA-WVS was used to assess CAD and the prognostic capacity of TAPB scores. Data analysis included the coronary artery calcification score (CACS), CAD status and extent, and TAPB score, calculated as the sum of plaque thickness and plaque angle at five thoracic aortic segments. The primary endpoint was MACE defined as a composite event comprised of ischemic stroke, acute coronary syndrome, and cardiovascular death. Results: During a mean follow-up period of 2.8±0.9 years, 40 of 455 (8.8%) patients experienced MACE. In the Cox proportional hazards model adjusted for clinical risks (Suita cardiovascular disease risk score), we identified TAPB score (T3) as a predictor of MACE independent of CACS >400 (hazards ratio [HR], 2.91; 95% confidence interval [CI], 1.26-6.72; p=0.012) or obstructive CAD (HR, 2.83; 95% CI, 1.30-6.18; p=0.009). The area under the curve for predicting MACE improved from 0.75 to 0.795 (p value=0.008) when TAPB score was added to CACS >400 and obstructive CAD. Conclusions: We found that comprehensive non-invasive evaluation of TAPB and CAD has prognostic value in MACE risk stratification for suspected CAD patients undergoing CCTA.